Nicotinamide Riboside#4 NR Email Launch Tomorrowsent 2024-09-17 · open 30.0% · CTR 0.27% · rev/recipient $0.128subject: A Word From Our CEO on NR← back to report · Klaviyo ↗
Archived copy of the sent template. Personalization tags ({{ first_name }}) unrendered; unsubscribe/footer tags removed.